38 related articles for article (PubMed ID: 12491106)
1. Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly.
Theeten H; Mathei C; Peeters K; Ogunjimi B; Goossens H; Ieven M; Van Damme P; Cools N
Viral Immunol; 2016 Apr; 29(3):169-75. PubMed ID: 27002465
[TBL] [Abstract][Full Text] [Related]
2. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.
Wang Z; La Rosa C; Li Z; Ly H; Krishnan A; Martinez J; Britt WJ; Diamond DJ
Vaccine; 2007 Jan; 25(6):1132-41. PubMed ID: 17049414
[TBL] [Abstract][Full Text] [Related]
3. Cytokine responses to major human Cytomegalovirus antigens in mouse model.
Essa S; Safar HA; Raghupathy R
Cytokine; 2024 Apr; 176():156546. PubMed ID: 38359558
[TBL] [Abstract][Full Text] [Related]
4. Circular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infection.
Shen L; Yang J; Zuo C; Xu J; Ma L; He Q; Zhou X; Ding X; Wei L; Jiang S; Ma L; Zhang B; Yang Y; Dong B; Wan L; Ding X; Zhu M; Sun Z; Wang P; Song X; Zhang Y
Mol Ther; 2024 Jan; 32(1):168-184. PubMed ID: 37974400
[TBL] [Abstract][Full Text] [Related]
5. The influence of HLA A, B, C, DR alleles and HLA haplotypes on cytomegalovirus-specific cell mediated immunity in seropositive Korean kidney transplant candidates.
Lee H; Kang H; Yun S; Ryu JH; Bae H; Chung BH; Yang CW; Oh EJ
HLA; 2023 Nov; 102(5):590-598. PubMed ID: 37158113
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy.
Kampouri E; Ibrahimi SS; Xie H; Wong ER; Hecht JB; Sekhon MK; Vo A; Stevens-Ayers TL; Green DJ; Gauthier J; Maloney DG; Perez A; Jerome KR; Leisenring WM; Boeckh MJ; Hill JA
Clin Infect Dis; 2024 Apr; 78(4):1022-1032. PubMed ID: 37975819
[TBL] [Abstract][Full Text] [Related]
7. Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-γ Cytokine Capture System.
Kim N; Nam YS; Im KI; Lim JY; Jeon YW; Song Y; Lee JW; Cho SG
Transfus Med Hemother; 2018 Jan; 45(1):13-22. PubMed ID: 29593456
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytomegalovirus-specific T-cell responses in patients with hypertension: comparison of assay methods and antigens.
Youn JC; Kim JY; Jung MK; Yu HT; Park SH; Kim IC; Lee SK; Choi SW; Han S; Ryu KH; Park S; Shin EC
Clin Hypertens; 2018; 24():5. PubMed ID: 29568571
[TBL] [Abstract][Full Text] [Related]
9. Establishment and application of a point-of-care testing and diagnosis method for early immediate expression gene IE1 of cytomegalovirus in maternal urine based on isothermal amplification.
Chu C; Yu S; Min F; Sun L; Liu M; Meng Q
Virus Res; 2023 Nov; 337():199229. PubMed ID: 37769815
[TBL] [Abstract][Full Text] [Related]
10. Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice.
Hsieh AH; Jhou YJ; Liang CT; Chang M; Wang SL
Arthritis Res Ther; 2011; 13(5):R162. PubMed ID: 21989080
[TBL] [Abstract][Full Text] [Related]
11. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus (CMV)-specific cellular immune responses.
Harari A; Zimmerli SC; Pantaleo G
Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
[TBL] [Abstract][Full Text] [Related]
13. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
Maecker HT; Maino VC
Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
[TBL] [Abstract][Full Text] [Related]
14. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
[TBL] [Abstract][Full Text] [Related]
15. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
